Fig. 4From: Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing miceLinear regression plots showing the correlation between tumor uptake assessed by PET imaging (PET/CT: A, C; PET/MR: B, D) and ex vivo biodistribution for [18F]FDG (A, B) and [89Zr]Zr-DFO-NCS-trastuzumab (C, D)Back to article page